Industry Portals
Biotechnical Industry News
Integer a velit nec risus malesuada imperdiet id et odio. Nunc sit amet mauris dapibus, feugiat diam eget, suscipit, nam gravida nulla eget turpis commodo.
Chemical M&A trends shift down (ICIS Chemical Business August 26 – September 1, 2022)
Young & Partners shows that global disruptions and uncertainties are suppressing M&A, Stock Prices and Financings.
Pharm Exec: Navigating the Financial Meltdown for Biopharma (Young & Partners article – August 2022 issue)
A review of pharma and biotech equity market, IPO, and M&A trends and disruptions through the first half of 2022 and the implications for the future.
Disruptions Suppress M&A and Financing (ICIS Chemical Business (May 20-26, 2022 issue)
Young & Partners dissects how disruptions and uncertainties are depressing M&A, equity prices and debt financings
Structural Changes and Disruptions (ICIS Chemical Business April 8 – April 21 2022)
Young & Partners covers the changes the chemical industry is facing now and will face in the future
Pharm Exec: Biopharma in 2021 Big Gains, Volatile Values (Young & Partners article – March 2022)
Young & Partners View of the Strategic, M&A and Financial trends in 2021 and outlook
Pharm Exec: China Invests in Building Biotech (Young & Partners comments – January 2022)
Young & Partners comments on what to expect from China in this article
Chemicals M&A to be resilient in 2022 (ICIS Chemical Business February 11 – February 17 2022)
Young & Partners reviews the developments through yearend and the outlook for 2022
Société de Chimie Industrielle Webcast: The Chemical Industry Outlook
Joseph Chang, Global Editor, ICIS Chemical Business; Robert Westervelt, Editor in Chief, IHS Markit Chemical Week
New Supply Chains (ICIS Chemical Business November 26 – December 2 2021)
Takeaways from Senior Chemical Executive Conference Panel on Reimagining Supply Chain Strategies
Chemical Economic, M&A and Financing (ICIS Chemical Business November 19-26 2021)
Comprehensive look at the economic, stock market, M&A and financing trends and outlook
Young & Partners 2021 Chemical Conference: Reimagining Supply Chain Strategies
Raj Gupta, Chairman, APTIV plc; Prakash Chandrasekar, Managing Director & Partner, Boston Consulting Group
Young & Partners 2021 Chemical Conference: The Industry Outlook
Joseph Chang, Global Editor, ICIS Chemical Business; Robert Westervelt, Editor in Chief, IHS Chemical Week
Young & Partners 2021 Chemical Conference: Peter Young – ESG: What Do You Need to Do?
Peter Young, on Environmental, Social & Governance pressures, describes the landscape and characterizes the implications for Chemical companies.
Young & Partners 2021 Chemical Conference: Edward Breen Fireside Chat: Leading Company Transformations
Edward Breen, Executive Chairman & CEO, DuPont de Nemours, Inc.
Young & Partners 2021 Pharmaceutical Executive Summit: Strategic Challenges Facing the BioPharma Industry
Lisa Henderson, Editor-in-Chief, Pharmaceutical Executive; Michael Shih, Head of Business Development, Biogen
Young & Partners 2021 Pharmaceutical Executive Summit: Doug Long: The Pharmaceutical Market: Trends, Issues and Outlook
Doug Long, Vice President, IQVIA Holdings Inc.
Young & Partners 2021 Pharmaceutical Executive Summit: Stephen Cutler: Innovation in Clinical Development
Dr. Stephen Cutler, CEO, ICON plc
Young & Partners 2021 Pharmaceutical Executive Summit: Christopher Austin Keynote Speech & Fireside Chat: How Cutting Edge Science is Driving the Development of New Medical Products
Dr. Christopher Austin, CEO-Partner, Flagship Pioneering